Position in NTRA
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,628
+$1,029 QoQ
Shares Held
6
+100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#809
of 844 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Physician Wealth Advisors, Inc. holds $574,855 across 27 Diagnostics & Research names. NTRA ranks #22 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
548 | $274,745 | |
| 2 | DHR |
Danaher Corp /De/
|
451 | $85,906 | |
| 3 | WAT |
Waters Corp /De/
|
193 | $72,382 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
69 | $36,324 | |
| 5 | A |
Agilent Technologies, Inc.
|
133 | $17,666 | |
| 6 | GH |
Guardant Health, Inc.
|
101 | $15,153 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
|
43 | $9,751 | |
| 8 | MYGN |
Myriad Genetics Inc
|
1,524 | $8,702 |
All Filings in NTRA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,628 | 6 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $599 | 3 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,603 | 7 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $482 | 3 | Shares | Sole | 2025-11-04 | |
| No filing history on record for this holder in this stock. | ||||||